Medicine guide
Ytracis
·
- Prescription status not stated
- Everything that fits nowhere else, such as contrast media
- Active substance
- Yttrium [90Y] chloride
- Made by
- CIS bio international
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- To be used only for the radiolabelling of carrier molecules which have been specifically developed and authorised for radiolabelling with this radionuclide.Radiopharmaceutical precursor - Not intended for direct application to patients.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | CIS bio international |
|---|---|
| Active substance | Yttrium [90Y] chloride |
| Used in | Everything that fits nowhere else, such as contrast media |
| Classification | V09 · Everything that fits nowhere else, such as contrast media |
| Authorised on | 2003-03-24 |
| Last updated by the regulator | 2022-01-19 |
| EMA product number | EMEA/H/C/000460 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.